These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 10609595)
1. Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community. Lorvick J; Thompson S; Edlin BR; Kral AH; Lifson AR; Watters JK J Urban Health; 1999 Dec; 76(4):461-7. PubMed ID: 10609595 [TBL] [Abstract][Full Text] [Related]
2. Tuberculosis prevention in methadone maintenance clinics. Effectiveness and cost-effectiveness. Snyder DC; Paz EA; Mohle-Boetani JC; Fallstad R; Black RL; Chin DP Am J Respir Crit Care Med; 1999 Jul; 160(1):178-85. PubMed ID: 10390397 [TBL] [Abstract][Full Text] [Related]
4. Adherence to isoniazid prophylaxis in the homeless: a randomized controlled trial. Tulsky JP; Pilote L; Hahn JA; Zolopa AJ; Burke M; Chesney M; Moss AR Arch Intern Med; 2000 Mar; 160(5):697-702. PubMed ID: 10724056 [TBL] [Abstract][Full Text] [Related]
5. A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users. Batki SL; Gruber VA; Bradley JM; Bradley M; Delucchi K Drug Alcohol Depend; 2002 May; 66(3):283-93. PubMed ID: 12062463 [TBL] [Abstract][Full Text] [Related]
6. Effect of directly observed preventive therapy for latent tuberculosis infection in San Francisco. White MC; Gournis E; Kawamura M; Menendez E; Tulsky JP Int J Tuberc Lung Dis; 2003 Jan; 7(1):30-5. PubMed ID: 12701832 [TBL] [Abstract][Full Text] [Related]
7. Material incentives and enablers in the management of tuberculosis. Lutge EE; Wiysonge CS; Knight SE; Volmink J Cochrane Database Syst Rev; 2012 Jan; 1():CD007952. PubMed ID: 22258976 [TBL] [Abstract][Full Text] [Related]
8. Impacts of 12-dose regimen for latent tuberculosis infection: Treatment completion rate and cost-effectiveness in Taiwan. Huang YW; Yang SF; Yeh YP; Tsao TC; Tsao SM Medicine (Baltimore); 2016 Aug; 95(34):e4126. PubMed ID: 27559940 [TBL] [Abstract][Full Text] [Related]
9. Directly observed isoniazid preventive therapy for released jail inmates. Nolan CM; Roll L; Goldberg SV; Elarth AM Am J Respir Crit Care Med; 1997 Feb; 155(2):583-6. PubMed ID: 9032198 [TBL] [Abstract][Full Text] [Related]
10. House calls by community health workers and public health nurses to improve adherence to isoniazid monotherapy for latent tuberculosis infection: a retrospective study. Chang AH; Polesky A; Bhatia G BMC Public Health; 2013 Sep; 13():894. PubMed ID: 24073620 [TBL] [Abstract][Full Text] [Related]
11. Impact of monetary incentives on adherence to referral for screening chest x-rays after syringe exchange-based tuberculin skin testing. Perlman DC; Friedmann P; Horn L; Nugent A; Schoeb V; Carey J; Salomon N; Des Jarlais DC J Urban Health; 2003 Sep; 80(3):428-37. PubMed ID: 12930881 [TBL] [Abstract][Full Text] [Related]
12. Strategies for effective education in a jail setting: the Tuberculosis Prevention Project. White MC; Duong TM; Cruz ES; Rodas A; McCall C; Menéndez E; Carmody ER; Tulsky JP Health Promot Pract; 2003 Oct; 4(4):422-9. PubMed ID: 14611027 [TBL] [Abstract][Full Text] [Related]
13. Adherence to isoniazid preventive chemotherapy: a prospective community based study. Marais BJ; van Zyl S; Schaaf HS; van Aardt M; Gie RP; Beyers N Arch Dis Child; 2006 Sep; 91(9):762-5. PubMed ID: 16737993 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program. Perlman DC; Gourevitch MN; Trinh C; Salomon N; Horn L; Des Jarlais DC J Urban Health; 2001 Sep; 78(3):550-67. PubMed ID: 11564856 [TBL] [Abstract][Full Text] [Related]
15. Incentives vs outreach workers for latent tuberculosis treatment in drug users. Malotte CK; Hollingshead JR; Larro M Am J Prev Med; 2001 Feb; 20(2):103-7. PubMed ID: 11165450 [TBL] [Abstract][Full Text] [Related]
16. Can the poor adhere? Incentives for adherence to TB prevention in homeless adults. Tulsky JP; Hahn JA; Long HL; Chambers DB; Robertson MJ; Chesney MA; Moss AR Int J Tuberc Lung Dis; 2004 Jan; 8(1):83-91. PubMed ID: 14974750 [TBL] [Abstract][Full Text] [Related]
17. Acceptance and safety of directly observed versus self-administered isoniazid preventive therapy in aboriginal peoples in British Columbia. Heal G; Elwood RK; FitzGerald JM Int J Tuberc Lung Dis; 1998 Dec; 2(12):979-83. PubMed ID: 9869112 [TBL] [Abstract][Full Text] [Related]
18. Use of incentives to increase compliance for TB screening in a population of intravenous drug users. Vancouver Injection Drug Use Study Group. FitzGerald JM; Patrick DM; Strathdee S; Rekart M; Elwood RK; Schecter MT; Montaner J; O'Shaughnessy M Int J Tuberc Lung Dis; 1999 Feb; 3(2):153-5. PubMed ID: 10091882 [TBL] [Abstract][Full Text] [Related]
19. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease. Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208 [TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. Chaisson RE; Barnes GL; Hackman J; Watkinson L; Kimbrough L; Metha S; Cavalcante S; Moore RD Am J Med; 2001 Jun; 110(8):610-5. PubMed ID: 11382368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]